From: Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
Variable | Haz. ratio | p-value | [95% Conf. Interval] | |
---|---|---|---|---|
Sex | Â | Â | Â | |
male | 1.463 | 0.271 | 0.743 | 2.879 |
(ref. female) | 1.092 | 0.842 | 0.459 | 2.600 |
2.489 | 0.211 | 0.596 | 10.389 | |
Age | Â | Â | Â | Â |
50- < 60 years | 1.745 | 0.317 | 0.586 | 5.195 |
(ref. <50 years) | 1.454 | 0.545 | 0.433 | 4.882 |
1.552 | 0.760 | 0.092 | 26.033 | |
Age | Â | Â | Â | Â |
60- < 70 years | 2.270 | 0.085 | 0.892 | 5.778 |
(ref. <50 years) | 2.271 | 0.118 | 0.811 | 6.358 |
1.068 | 0.957 | 0.102 | 11.210 | |
Age | Â | Â | Â | Â |
≥70 years | 6.112 | 0.001 | 2.087 | 17.903 |
(ref. <50 years) | 9.923 | 0.000 | 2.808 | 35.062 |
2.774 | 0.376 | 0.290 | 26.572 | |
Mean methylation level (Continuous) | Â | Â | Â | Â |
1.003 | 0.736 | 0.986 | 1.021 | |
0.998 | 0.836 | 0.977 | 1.019 | |
 | 1.018 | 0.430 | 0.974 | 1.065 |